Haypp Group

Haypp Group is leading the global shift from smoking to reduced risk alternatives. Our vision is to inspire a smoke free future for millions.

[Haypp Group @HayppGroup]

Haypp's view on recent FDA nic pouch guidance & implications. As our US president notes, "responsible retail for nicotine pouch sales online, requires real structure and measurable controls, not good intentions."

https://t.co/2jkXsnDGIg

$HAYPP $PM $PMI $BATS $BTI $MO $IMB $TPB

[Haypp Group @HayppGroup]

Another important Reuters article looking at the effect of FDA's recent guidance, noting that this change "will potentially unleash hundreds more such products on the market in the coming weeks and months"

https://t.co/OTpS0aBqSx

$HAYPP $PM $PMI $MO $BATS $BTI $IMB $TPB $JTI

[Haypp Group @HayppGroup]

From the guidance:
...does not intend to prioritize enforcement of the premarket authorization requirement,
where the product:
• is subject to an application that is pending, and the application has been accepted and
filed ...and pending for more than 180 days;

$HAYPP

[Haypp Group @HayppGroup]

"FDA does not intend to prioritize if a product has a pending application that has been accepted and filed"

$HAYPP $PMI $PM $BATS $BTI $MO $TPB $IMB

[Haypp Group @HayppGroup]

"FDA does not intend to prioritize if a product has a pending application that has been accepted and filed"

$HAYPP $PMI $PM $BATS $BTI $MO $TPB $IMB

[Haypp Group @HayppGroup]

Very important FDA announcement : Guidance on Enforcement Priorities for Unauthorized ENDS and Nicotine Pouch Products. https://t.co/RpQLmwgIDI

[Haypp Group @HayppGroup]

Haypp released Q1 26 results today, w/ topline momentum accelerating. Group sales up 24% YoY in cc driven by 40% nicotine pouch growth

The Q1 report w/ new disclosures incl. volume & GM by segment is available at:
https://t.co/tptJ83oOY0

$HAYPP

[Haypp Group @HayppGroup]

Live consensus estimates are also now available on HayppGroup

https://t.co/TzBZK8YFr7

$HAYPP

[Haypp Group @HayppGroup]

Our upcoming Q1 26 results will be released at 0745 Stockholm on 7 May, with a conference call webcast at 0900.

Consensus estimates from 4 IBs (Barclays, DB, DNBC, Pareto) are available at :
https://t.co/hVZwq77ikf

$HAYPP

[Haypp Group @HayppGroup]

Reuters FDA sources say delay in nicotine pouch accelerated reviews, “due to a cautious approach by agency reviewers…[as] the scientific evidence for speeding them through was not as clear-cut as expected.”


https://t.co/m1RFnqFqsl

$HAYPP $BATS $BTI $PM $MO $TPB $IMB $JTI

[Haypp Group @HayppGroup]

Haypp is pleased to announce that on! PLUS nicotine pouches, produced by Altria are now available on Haypp’s US sites https://t.co/UapkktTVzh and https://t.co/2sqHJK3Om4. See the link for more detail.

https://t.co/8ZEoNOh7IY

$HAYPP $MO

[Haypp Group @HayppGroup]

Positive developments from EESC on Euro TTD

"Together with the prevention of excessive tax increases, the principle of risk-proportionate taxation is at the heart of the committee's recommendations."

https://t.co/kzGJwmYc64

$HAYPP $PMI $BATS $BTI $JTI $IMB $STG $MO

[Haypp Group @HayppGroup]

Notable argument by the IMF that taxation should reflect harm.

“Ideally, the level of taxation should reflect the degree of harm a product is likely to cause while still safeguarding overall revenue.”



https://t.co/zHxaSR4ypW

$HAYPP $PM $MO $BATS $BTI $IMB $JTI $TPB $STG

[Haypp Group @HayppGroup]

Another insightful argument explaining the resistance by some in tobacco control to offering consumers lower risk products than cigarettes that they switch to without coercion.

$HAYPP $PM $BATS $BTI $MO $IMB $JTI $TPB

[Clive Bates @Clive_Bates]

The easiest play in tobacco control is also the dumbest. My new post on why the Irreconcilable Conflict Principle (a fancy version of the “scream test”) distorts science, policy and truth... with 8 examples.
https://t.co/Ix3HBig5D8

[Clive Bates @Clive_Bates]

EU Health Commissioner @OliverVarhelyi is spreading absurd disinformation about tobacco and nicotine risks.

23 experts write to explain the damage to EU citizens and the credibility of EU policymaking.

CC: @vonderleyen, @steph_sejourne, @EU_Health

https://t.co/QIjasyzurR

[Haypp Group @HayppGroup]

An important critique by a prominent public health veteran of WHO's approach to smoking and reduced risk nicotine products and why it is flawed.

$HAYPP $PM $BATS $BTI $IMB $JTI $STG $MO

[Clive Bates @Clive_Bates]

The WHO is a risk factor for cancer
https://t.co/JQk9t5qwm5
In a new Code Against Cancer, the World Health Organisation opposes the most effective and popular way to reduce the most important modifiable cancer risk, smoking.

So, what does that make WHO?

[Haypp Group @HayppGroup]

Haypp at UBS Global Consumer and Retail Conference 12 March.

https://t.co/D7cMXUZAo1

$HAYPP

[Haypp Group @HayppGroup]

Our presentation slides and Excel with financial data can be found below. The transcript from the first CC will be posted here as well.

https://t.co/tptJ83pmNy

$HAYPP

[Haypp Group @HayppGroup]

Haypp announced its Q4 25 results earlier today. The report is available at the below link, with webcast of the presentation + Q&A at 0900 CET. A 2nd presentation + Q&A will be held at 1600 CET / 1000 Eastern.

https://t.co/LRC4Uo542v

$HAYPP

[Haypp Group @HayppGroup]

Haypp's Q4 2025 results presentation + Q&A will be webcast 13 Feb at 0900 CET w/ a 2nd webcast + Q&A at 1000 Eastern. Investors, analysts and media are invited to participate in the call using details in the link.

https://t.co/kFP5sdFyal

$HAYPP

[Haypp Group @HayppGroup]

A thought provoking article about science around nicotine products. "Instead of asking whether a claim is true, critics ask where the claimant sits in relation to the industry."
Conflict of Interest - Redefined...
https://t.co/2Ecx6i5fgR

$HAYPP $PM $MO $BATS $BTI $IMB $JTI